Valeant Pharmaceuticals International Community Page | What other sites are saying about Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

(NY: VRX)

78.17 USD +2.42 (+3.19%)

Official Closing Price / Updated: 6:40 PM EDT, May 17, 2013 / Add to My Watchlist

(VRX) Community Analysis from

READ MORE (VRX)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 19, 2013

(VRX) Valeant Pharmaceuticals Beats Earnings – Misses Revenues

(Stock Blog Hub, 5/16/13)

Valeant Pharmaceuticals’ (VRX) first quarter 2013 earnings of $1.27 (excluding special items but including stock-based compensation expense) were short of the Zacks...(read more)

Why Ruane Cunniff & Weitz Funds Like Valeant Pharmaceuticals (VRX)

(market folly, 9/14/12)

We've seen past commentary from multiple managers on shares of Valeant Pharmaceuticals (VRX) and thought it was worth highlighting given that numerous respected managers own it. Hedge Fund...(read more)

Valeant’s Acquires Medicis & Could Dominate The US Dermatology Market

(ValueWalk.com, 9/4/12)

Valeant Pharmaceuticals Int (NYSE:VRX) (TSE:VRX) announced on Labor Day, a deal to acquire Medicis Pharmaceutical Corp (NYSE:MRX) in a $2.6 billion deal. The Medicis...(read more)

View all posts about Valeant Pharmaceuticals International (VRX)

Valeant Pharmaceuticals International (VRX) Company Overview

There is no analysis for VRX yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates